Stage III Breast Cancer Active Not Recruiting Phase 2 Trials for Tamoxifen (DB00675)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02311933Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerTreatment
NCT01831076Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 TumorsTreatment